Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
Merck Announces New Phase III Data for Suvorexant
Merck, known as MSD outside the United States and Canada, announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia.
REFINE
medications
Remove Suvorexant filter
(-)
Remove Suvorexant filter
Suvorexant
conditions
Apply Sleep Apnea Insomnia filter
Sleep Apnea Insomnia (1)
Apply Sleep Apnea Insomnia filter